首页> 美国卫生研究院文献>Frontiers in Physiology >Identifying potential functional impact of mutations and polymorphisms: linking heart failure increased risk of arrhythmias and sudden cardiac death
【2h】

Identifying potential functional impact of mutations and polymorphisms: linking heart failure increased risk of arrhythmias and sudden cardiac death

机译:识别突变和多态性的潜在功能影响:将心力衰竭心律不齐和心源性猝死的风险增加联系起来

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Researchers and clinicians have discovered several important concepts regarding the mechanisms responsible for increased risk of arrhythmias, heart failure, and sudden cardiac death. One major step in defining the molecular basis of normal and abnormal cardiac electrical behavior has been the identification of single mutations that greatly increase the risk for arrhythmias and sudden cardiac death by changing channel-gating characteristics. Indeed, mutations in several genes encoding ion channels, such as SCN5A, which encodes the major cardiac Na+ channel, have emerged as the basis for a variety of inherited cardiac arrhythmias such as long QT syndrome, Brugada syndrome, progressive cardiac conduction disorder, sinus node dysfunction, or sudden infant death syndrome. In addition, genes encoding ion channel accessory proteins, like anchoring or chaperone proteins, which modify the expression, the regulation of endocytosis, and the degradation of ion channel a-subunits have also been reported as susceptibility genes for arrhythmic syndromes. The regulation of ion channel protein expression also depends on a fine-tuned balance among different other mechanisms, such as gene transcription, RNA processing, post-transcriptional control of gene expression by miRNA, protein synthesis, assembly and post-translational modification and trafficking. The aim of this review is to inventory, through the description of few representative examples, the role of these different biogenic mechanisms in arrhythmogenesis, HF and SCD in order to help the researcher to identify all the processes that could lead to arrhythmias. Identification of novel targets for drug intervention should result from further understanding of these fundamental mechanisms.
机译:研究人员和临床医生已经发现了一些重要的概念,涉及导致心律不齐,心力衰竭和心源性猝死风险增加的机制。定义正常和异常心脏电行为的分子基础的一个主要步骤是鉴定单个突变,这些突变通过改变通道门控特征极大地增加了心律不齐和心脏猝死的风险。确实,一些编码离子通道的基因的突变,例如编码主要心脏Na + 通道的SCN5A,已经成为多种遗传性心律不齐的基础,例如长QT综合征,Brugada综合征。 ,进行性心脏传导障碍,窦房结功能障碍或婴儿猝死综合征。此外,也已经报道了编码离子通道辅助蛋白(如锚定蛋白或伴侣蛋白)的基因,这些蛋白改变了表达,内吞作用的调节以及离子通道α-亚基的降解,成为心律不齐综合征的易感基因。离子通道蛋白表达的调控还取决于其他不同机制之间的微调平衡,例如基因转录,RNA加工,miRNA对基因表达的转录后控制,蛋白质合成,组装以及翻译后修饰和运输。这篇综述的目的是通过描述几个代表性的例子来概述这些不同的生物发生机制在心律不齐,HF和SCD中的作用,以帮助研究人员确定所有可能导致心律不齐的过程。对药物干预的新靶标的确定应来自对这些基本机制的进一步理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号